Price target
15.090.000.00%
The 10 analysts offering 1 year price forecasts for 2607 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 12 analysts giving stock ratings to 2607 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
2607 EPS for the last quarter is 0.33 HKD despite the estimation of 0.30 HKD. In the next quarter EPS is expected to reach 0.24 HKD. Track more of SHANGHAI PHARMACEUTICALS HOLDING CO financials and stay on top of what is up with the company.
In the next quarter SHANGHAI PHARMACEUTICALS HOLDING CO revenue is expected to reach 76.05 B HKD. Check out SHANGHAI PHARMACEUTICALS HOLDING CO revenue and earnings and make informed decisions.
According to analysts, 2607 price target is 15.09 HKD with a max estimate of 18.10 HKD and a min estimate of 12.70 HKD. Check if this forecast comes true in a year, meanwhile watch SHANGHAI PHARMACEUTICALS HOLDING CO stock price chart and keep track of the current situation with 2607 news and stock market news.
We've gathered opinions of 12 analysts rating 2607 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.